Document is current
Any future updates will be listed below
-
Authors
Carmona-Rivera, Carmelo https://orcid.org/0000-0002-7706-1464
O’Neil, Liam J.
Patino-Martinez, Eduardo
Ambler, William G.
Mallela, Teja
Hanata, Norio https://orcid.org/0000-0002-0195-4039
Zadu, Arsema K.
Jiang, Kan https://orcid.org/0000-0001-9065-4574
Okoye, Ginette A.
Byrd, Angel S.
Sayed, Christopher J.
Kaplan, Mariana J. https://orcid.org/0000-0003-2968-0815
-
Funding
Funding for this research was provided by:
Skin of color Society-CDA
U.S. Department of Health & Human Services | National Institutes of Health (1R21AR075996)
U.S. Department of Health & Human Services | National Institutes of Health (1R01AR083790-01A1)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (ZIA AR041199)
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 4 March 2026
First Online: 24 March 2026
Competing interests
: ASB is a consultant for Senté, Inc. GAO is on an Advisory Board for Pfizer, UCB, Eli Lilly, and Novartis and a consultant for Janssen. CJS serves as Secretary of the Board of Directors for HS Foundation, speaker for AbbVie, Novartis and UCB, a consultant for AbbVie, Novartis, UCB, Sanofi, Incyte, InfaRx, Astrazeneca, Navigator Medicines, Moonlake Therapeutics and Elasmogen, and an investigator for Novartis, UCB, Incyte, InflaRx and Astrazeneca. All other authors declare no conflict of interest.
